Jul 11, 2017 5:31:00 AM |
July 11, 2017 (Boston, MA) – Covington Associates LLC, a leading middle market investment bank announced its role as exclusive advisor to Phase 2 Medical Manufacturing, Inc., a manufacturer of a wide variety of Class I, II and III single-use instruments and disposable medical devices, on the sale of its business to Nexcore Technology, LLC, an FDA registered and ISO 13485 certified contract manufacturer of electro-mechanical capital equipment to the medical device industry.
“Nexcore’s acquisition of Phase 2 adheres to our strategy of creating a leading contract manufacturer focused exclusively on the medical device industry. The combination of Nexcore and Phase 2 allows us to quickly establish a leading contract manufacturing suppler for medical device OEMs. The new company offers customers a full suite of services across a comprehensive range including concept, feasibility, design, development, manufacturing and after-market services. Additionally, we have diversified our customer base, gained access to a new market segment, expanded our geographic presence and enabled the two companies to share best practices,” said Ken Heuer, a KCO Principal and Nexcore Board member.
Carlo W. Colesanti, Nexcore’s President and CEO stated, “Phase 2 has developed a world-class team that has been pleasing customers for more than two decades, and this acquisition will permit us to create a deeper toolbox of solutions, expand our value proposition, and enhance our ability to serve customers and offer them a unified, ‘single-source of supply’ for a variety of complex manufacturing and service needs for medical capital equipment and single-use disposable devices. They have been doing a wonderful job and we intend for that to continue as we look forward to building on the foundation created by Phase 2 and continuing to grow Nexcore by serving the increasing needs of our collective customers.”
Adam Prime, Phase 2’s President prior to the acquisition, will assume a new role as Sr. Vice President & Chief Lean Officer of the newly combined businesses. Mr. Prime said, “I am truly excited by the prospects for our business and the related advantages our customers and employees will experience together with Nexcore. I look forward to working closely with Carlo, the management team, and KCO to continue to build an industry-leading company.”
Eaglehill Advisors LLC, Plexus Capital, and Spring Capital Partners, LLC provided mezzanine debt and co-equity investments, and J.P. Morgan Chase provided senior debt financing in support of the transaction.
About Covington Associates LLC
Covington Associates is an investment banking firm offering advisory services in the areas of mergers and acquisitions (“M&A”), capital raising, strategic advisory, fairness opinions, and valuations to middle-market companies across the Healthcare, Business Services, Consumer & Industrial, and Technology verticals. Founded in 1991, with offices in Boston, and New York, the vision for Covington has been to provide clients with the highest caliber of senior-level attention and to remain an advice driven and results focused organization. Since its inception, Covington Associates has completed more than 200 transactions globally for both private and publicly traded companies totaling over $15 billion.
Founded by Milton Frank in 1999, Nexcore is a contract manufacturer of electro-mechanical capital equipment to the medical device industry. The Company has a strong track record of growth and an outstanding reputation with its customers based upon its leading technical capabilities, high quality standards, on-time performance and customer service. The Company’s capabilities cover the complete spectrum of the medical device manufacturing product life cycle, from conceptual design and engineering through to manufacturing and after-market service and support. The Company serves a variety of leading medical device OEMs with a portfolio of innovative medical devices. With its full suite of design and manufacturing capabilities and focus on all aspects of customer service, Nexcore positions itself not just as a supplier but as a true value-added partner to its OEM customers. For more information, visit www.nexcoretech.com.
About Phase 2
Founded by Garry Prime, Peter Prime and Mark Newbert in 1995, Phase 2 partners with medical device market leaders and innovators to design, assemble, and package single-use instruments and disposables. With comprehensive design and manufacturing capabilities, we help customers at each stage of the product life-cycle from device innovation, to new product introduction, program transfers, or end-of-life programs. The Company is 100% focused on design and manufacturing of Class I, II and III single-use instruments and disposable medical devices. At Phase 2, LEAN is more than a process, it is a culture, and benefits of the Company’s LEAN systems can be realized through supply chain, warehousing, assembly, testing, packaging, sterilization, and distribution. For more information, visit www.phase2medical.com.
99 Summer Street, Suite 200 Boston, Massachusetts 02110
Broker Dealer Services
Provided Through Covington Associates, LLC. Member FINRA/SIPC.
© 2017 Covington Associates All Rights Reserved.